Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Biochemical Pharmacology
|
August 17, 1993
Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Effects of ATP concentration, anion concentration, and the three-dimensional structure of the DNA target
J Mayes, M Hinds, L Soares, et al.
Biochemical Pharmacology
|
March 1, 1991
Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase II gene expression in human leukemia cells
L A Zwelling, D Chan, E Altschuler, et al.
Cancer Research
|
November 15, 1990
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation
L A Zwelling, M Hinds, D Chan, et al.
Biochemical Pharmacology
|
July 20, 1993
Activity of two novel anthracene-9,10-diones against human leukemia cells containing intercalator-sensitive or -resistant forms of topoisomerase II
L A Zwelling, J Mayes, E Altschuler, et al.
Nucleic Acids Research
|
September 24, 2013
The tenacious recognition of yeast telomere sequence by Cdc13 is fully exerted by a single OB-fold domain
Karen A Lewis, Danielle A Pfaff, Jennifer N Earley, et al.
Cancer Research
|
September 1, 1991
Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II
M Hinds, K Deisseroth, J Mayes, et al.
Cancer Research
|
January 1, 1992
Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development
L A Zwelling, M J Mitchell, P Satitpunwaycha, et al.
Biochemical Pharmacology
|
January 20, 1994
Phorbol regulation of topoisomerases I and II in human leukemia cells. Studies in an additional cell pair sensitive or resistant to phorbol-induced differentiation
A L Ellis, E Altschuler, E Bales, et al.
Neurosurgery Clinics of North America
|
January 1, 1992
Radiobiologic models for radiosurgery
E Altschuler, L D Lunsford, D Kondziolka, et al.
The American Journal of Gastroenterology
|
July 26, 2006
Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism
Patrick G Northup, Matthew M McMahon, A Parker Ruhl, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Biochemical Pharmacology
|
August 17, 1993
Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Effects of ATP concentration, anion concentration, and the three-dimensional structure of the DNA target
J Mayes, M Hinds, L Soares, et al.
Biochemical Pharmacology
|
March 1, 1991
Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase II gene expression in human leukemia cells
L A Zwelling, D Chan, E Altschuler, et al.
Cancer Research
|
November 15, 1990
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation
L A Zwelling, M Hinds, D Chan, et al.
Biochemical Pharmacology
|
July 20, 1993
Activity of two novel anthracene-9,10-diones against human leukemia cells containing intercalator-sensitive or -resistant forms of topoisomerase II
L A Zwelling, J Mayes, E Altschuler, et al.
Nucleic Acids Research
|
September 24, 2013
The tenacious recognition of yeast telomere sequence by Cdc13 is fully exerted by a single OB-fold domain
Karen A Lewis, Danielle A Pfaff, Jennifer N Earley, et al.
Cancer Research
|
September 1, 1991
Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II
M Hinds, K Deisseroth, J Mayes, et al.
Cancer Research
|
January 1, 1992
Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development
L A Zwelling, M J Mitchell, P Satitpunwaycha, et al.
Biochemical Pharmacology
|
January 20, 1994
Phorbol regulation of topoisomerases I and II in human leukemia cells. Studies in an additional cell pair sensitive or resistant to phorbol-induced differentiation
A L Ellis, E Altschuler, E Bales, et al.
Neurosurgery Clinics of North America
|
January 1, 1992
Radiobiologic models for radiosurgery
E Altschuler, L D Lunsford, D Kondziolka, et al.
The American Journal of Gastroenterology
|
July 26, 2006
Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism
Patrick G Northup, Matthew M McMahon, A Parker Ruhl, et al.
Page
of 4